Paper42579698
Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling.
Vu LT and 8 others. PLoS One, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling. Papers, record 42579698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42579698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanistic insights into daidzin from Glycine max against breast cancer via network pharmacology and multi-level molecular modeling.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Isoflavones | Major topic |
| Glycine max | Major topic |
| Network Pharmacology | Major topic |
| Humans | |
| Female | |
| Matrix Metalloproteinase 9 | |
| Molecular Docking Simulation | |
| Protein Interaction Maps | |
| Molecular Dynamics Simulation | |
| Models, Molecular | |
| Benzamides | |
| Naphthols |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25860834 | pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. | J Med Chem | 2015 | https://conductscience.org/library/papers/25860834 | PubMed |
| 2 | 33635003 | Understanding cell-cell communication and signaling in the colorectal cancer microenvironment. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/33635003 | PubMed |
| 3 | 34333227 | Tracking the interaction between single-wall carbon nanotube and SARS-Cov-2 spike glycoprotein: A molecular dynamics simulations study. | Comput Biol Med | 2021 | https://conductscience.org/library/papers/34333227 | PubMed |
| 4 | 35024412 | Adverse events of targeted therapies approved for women's cancers. | Int J Womens Dermatol | 2021 | https://conductscience.org/library/papers/35024412 | PubMed |
| 5 | 25737294 | Electron flow in reaction mechanisms--revealed from first principles. | Angew Chem Int Ed Engl | 2015 | https://conductscience.org/library/papers/25737294 | PubMed |
| 6 | 16211538 | GROMACS: fast, flexible, and free. | J Comput Chem | 2005 | https://conductscience.org/library/papers/16211538 | PubMed |
| 7 | 35744803 | Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs. | Molecules | 2022 | https://conductscience.org/library/papers/35744803 | PubMed |
| 8 | 27723080 | The potential health effects of dietary phytoestrogens. | Br J Pharmacol | 2017 | https://conductscience.org/library/papers/27723080 | PubMed |
| 9 | 25451770 | CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. | Biosystems | 2015 | https://conductscience.org/library/papers/25451770 | PubMed |
| 10 | 17064189 | Koopmans' theorem for large molecular systems within density functional theory. | J Phys Chem A | 2006 | https://conductscience.org/library/papers/17064189 | PubMed |
| 11 | 33715811 | Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts. | J Lipid Res | 2020 | https://conductscience.org/library/papers/33715811 | PubMed |
| 12 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 13 | 19503817 | Information flow analysis of interactome networks. | PLoS Comput Biol | 2009 | https://conductscience.org/library/papers/19503817 | PubMed |
| 14 | 34371794 | Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34371794 | PubMed |
| 15 | 34073226 | The Role of Serotonin in Breast Cancer Stem Cells. | Molecules | 2021 | https://conductscience.org/library/papers/34073226 | PubMed |
| 16 | 9504803 | SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. | Electrophoresis | 1997 | https://conductscience.org/library/papers/9504803 | PubMed |
| 17 | 36133824 | Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning techniques. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36133824 | PubMed |
| 18 | 33841325 | Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33841325 | PubMed |
| 19 | 39647635 | Unlocking biological insights from differentially expressed genes: Concepts, methods, and future perspectives. | J Adv Res | 2025 | https://conductscience.org/library/papers/39647635 | PubMed |
| 20 | 22650234 | Network pharmacology for cancer drug discovery: are we there yet? | Future Med Chem | 2012 | https://conductscience.org/library/papers/22650234 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42579698
GET https://conductscience.org/api/papers/v1/42579698/references?page=2